Current Assets
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value
CVS Health AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value decreased by 21.2% to $2.74B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 45.6%, from $5.04B to $2.74B. Over 5 years (FY 2020 to FY 2025), AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value shows an upward trend with a 137.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2019
Last reportedQ1 2026May 6, 2026
Metric ID:
afs_trading_securities_unrealized_loss_12m_plus_fvHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $43.00M | $151.00M | $584.00M | $1.05B | $1.09B | $2.49B | $4.26B | $9.57B | $10.18B | $11.68B | $10.62B | $9.66B | $8.96B | $6.58B | $5.73B | $5.04B | $4.14B | $3.66B | $3.48B | $2.74B |
| QoQ Change | — | +251.2% | +286.8% | +79.1% | +4.5% | +127.7% | +71.3% | +124.5% | +6.4% | +14.7% | -9.1% | -9.0% | -7.3% | -26.5% | -12.9% | -12.2% | -17.8% | -11.5% | -5.1% | -21.2% |
| YoY Change | — | — | — | — | >999% | >999% | +630.1% | +815.1% | +831.7% | +369.1% | +149.0% | +1.0% | -12.0% | -43.6% | -46.0% | -47.9% | -53.8% | -44.4% | -39.4% | -45.6% |
Range$43.00M – $11.68B
CAGR+139.8%
Avg YoY Growth+403.3%
Median YoY Growth-5.5%
Current Streak10 quarters decline
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value at Other Companies
Frequently Asked Questions
- What is CVS Health's afs and trading securities - unrealized loss position (>=12 months) fair value?
- CVS Health (CVS) reported afs and trading securities - unrealized loss position (>=12 months) fair value of $2.74B in Q1 2026.
- How has CVS Health's afs and trading securities - unrealized loss position (>=12 months) fair value changed year-over-year?
- CVS Health's afs and trading securities - unrealized loss position (>=12 months) fair value decreased by 45.6% year-over-year, from $5.04B to $2.74B.
- What is the long-term trend for CVS Health's afs and trading securities - unrealized loss position (>=12 months) fair value?
- Over 5 years (2020 to 2025), CVS Health's afs and trading securities - unrealized loss position (>=12 months) fair value has grown at a 137.5% compound annual growth rate (CAGR), from $46.00M to $3.48B.